Oncology

Oncology Master Degree

Feel Free to Ask Questions!

Tel : +8615850513534

E-mail : apply@acasc.cn

  • Application Deadline:2018/09/30
  • Tuition:¥0.00
  • Application Fee:¥800.00
  • Service Fee:¥0.00
School Information

Hubei University of Medicine (HUM) is located in the center of Shiyan, the Motor City, in Hubei Province, People’s Republic of China. The city boasts several tourist attractions, such as Wudang Mountain, a sacred place of Taoism; Danjiangkou Reservoir, th

Find more information on the university website
How To Apply

Applying through ACASC generally takes a few minutes to complete. It takes 5 steps to complete the application.

1. Click “Apply Now” button at the top of the page.

2. Fill in online application form.

3. Upload required documents.

4. Pay the application fee and the ACASC service fee

5. Click “Submit” button.

Important notice: In order to apply, you need to create an account with ACASC.

Oncology is a branch of medicine that deals with the prevention, diagnosis and treatment of cancer. A medical professional who practices oncology is an oncologist. The name's etymological origin is the Greek word ὄγκος (ónkos), meaning "tumor", "volume" or "mass".

The three components which have improved survival in cancer are:

  1. Prevention - This is by reduction of risk factors like tobacco and alcohol consumption

  2. Early diagnosis - Screening of common cancers and comprehensive diagnosis and staging

  3. Treatment - Multimodality management by discussion in tumor board and treatment in a comprehensive cancer centre

Cancers are often managed through discussion on multi-disciplinary cancer conferences where medical oncologist, surgical oncologist, radiation oncologist, pathologist, radiologist and organ specific oncologists meet to find the best possible management for an individual patient considering the physical, social, psychological, emotional and financial status of the patients. It is very important for oncologists to keep updated of the latest advancements in oncology, as changes in management of cancer are quite common. All eligible patients in whom cancer progresses and for whom no standard of care treatment options are available should be enrolled in a clinical trial.


share_phone_icon share_facebook_icon share_twitter_icon share_youtube_icon share_pinterest_icon share_linkedin_icon share_instagram_icon email_icon top_icon